Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 21, Issue 2, Pages 249-251Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458514528759
Keywords
Fingolimod; multiple sclerosis; edema; steroid
Categories
Ask authors/readers for more resources
The occurrence of macular edema as an adverse effect of fingolimod is well documented. Treatment modalities used to manage fingolimod-associated macular edema (FAME) have included nonsteroidal anti-inflammatory agents and sub-tenon injection. We describe two cases where intravitreal injection is used to successfully treat FAME in patients who were previously unsuccessfully treated with topical nonsteroidal anti-inflammatories.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available